Locations

San Diego County

9500 Gilman Dr.
MC 0641
La Jolla, CA 92093-0641

Specialty

Kawasaki Disease

Organization

Rady Children's Specialists of San Diego

Medical Group / IPA

CPMG/RCHN/RCSSD

Medical School

University of North Carolina at Chapel Hill

Residency

Univ of Colorado - Denver

Fellowship

Univ of Colorado - Denver

Board Certifications

Pediatrics

Gender

F

Bio

Dr. Jane C. Burns is the director of the Kawasaki Disease Clinic at Rady Children's Hospital-San Diego and the Kawasaki Disease Research Center at UC San Diego. She is also a professor of pediatrics at UC San Diego School of Medicine.

After earning her medical degree at the University of North Carolina in Chapel Hill in 1978, she completed her pediatric residency and fellowship at the University of Colorado in Denver, followed by additional training in pediatric infectious diseases and molecular virology at Harvard Medical School and Boston Children's Hospital. She joined the faculty at Harvard Medical School in 1986 and moved to San Diego in 1990.

Internationally known for her research on Kawasaki disease (KD), her passion for studying KD has spanned almost three decades, with her first publication in 1982. In addition to her academic pursuits, Dr. Burns is the mother of two daughters. Her husband, John B. Gordon M.D., is an interventional cardiologist who cares for adults with long-term sequelae of KD. Together, working with a team from UC San Diego, they launched the Adult KD Collaborative, a long-range epidemiologic and clinical study of cardiovascular biomarkers and functional studies in adults who suffered from KD in childhood.

Publications

Cost-effectiveness analysis of second intravenous immunoglobulin infusion versus infliximab for treating IVIG-resistant Kawasaki disease patients.
Johnson JM, Simpson KN, Simpson AN, Tremoulet AH, Burns JC

The landscape of inter-institutional and multinational collaborations in Kawasaki disease.
Gutierrez Rojas R, Breault F, Alzyoud R, Ayusawa M, Barri AC, Belot A, Burns JC, Choueiter N, Corinaldesi E, Fabi M, Fernández-Cooke E, Gámez-González LB, Hamada H, Harahsheh A, Ikeda K, Jakob A, Johnson T, Kim GB, Kobayashi S, Kobayashi T, Kone-Paut I, Kotby A, Kuijpers TW, Kuipers IM, Manlhiot C, Mastrolia MV, Matsubara D, McCrindle BW, Mitani Y, Nakamura Y, Netea SA, Onouchi Y, Pal P, Philip S, Portman MA, Rudolph A, Singh S, Singh-Grewal D, Simonini G, Song MS, Toral Vázquez B, Ulloa-Gutierrez R, Webb K, Wollenweber E, Yamazaki-Nakashimada MA, Tremoulet AH, Dahdah N

Reply.
Tremoulet AH, Bellicini I, Bainto E, Shimizu C, Burns JC

Pathology of the Coronary Arteries and Myocardium in Kawasaki Disease.
Shimizu C, Pérez Pomares JM, Loy CJ, De Vlaminck I, Tremoulet AH, Ruiz-Villalba A, Burns JC

Molecular characterization of Kawasaki disease subgroups using cell-free RNA profiling.
Loy CJ, Wang H, Kim J, Shimizu C, Lenz J, Belcher E, Tremoulet AH, Burns JC, De Vlaminck I

External Validation of a Machine Learning Model to Diagnose Kawasaki Disease.
Lam JY, Shimizu C, Gardiner MA, Giorgio T, Wright V, Baker A, Anderson MS, Heizer H, Mohandas S, Kazarians A, Kaneta K, Jone PN, Dominguez SR, Szmuszkovicz JR, Newburger JW, Tremoulet AH, Burns JC

Cyclosporine Treatment in Patients with Kawasaki Disease and Coronary Artery Aneurysms or Treatment Resistance.
Bellicini I, Bainto E, Shimizu C, Burns JC, Tremoulet AH

A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome.
Khan R, Ji W, Guzman Rivera J, Madhvi A, Andrews T, Richlin B, Suarez C, Gaur S, Hasan UN, Cuddy W, Singh AR, Bukulmez H, Kaelber D, Kimura Y, Ganapathi U, Michailidis IE, Ukey R, Moroso-Fela S, Kuster JK, Casseus M, Roy J, Burns JC, Kleinman LC, Horton DB, Lakhani SA, Gennaro ML

The long-term vascular and myocardial outcomes in selected Kawasaki disease patients with regression of giant coronary artery aneurysms.
Kung SC, Miyata K, Colvert GM, Kahn AM, Daniels LB, Hoshino S, Dummer KB, Golding IF, Roberts S, Shimizu C, Tremoulet AH, McVeigh ER, Gordon JB, Burns JC

A phase I/IIa trial of atorvastatin in Japanese patients with acute Kawasaki disease and coronary artery aneurysms.
Furuno K, Suganuma E, Masuda H, Kano Z, Saito J, Shoji K, Imadome KI, Imai S, Kobayashi S, Shimizu C, Tremoulet AH, Burns JC, Kobayashi T

Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C).
Bellos E, Santillo D, Vantourout P, Jackson HR, Duret A, Hearn H, Seeleuthner Y, Talouarn E, Hodeib S, Patel H, Powell O, Yeoh S, Mustafa S, Habgood-Coote D, Nichols S, Estramiana Elorrieta L, D'Souza G, Wright VJ, Estrada-Rivadeneyra D, Tremoulet AH, Dummer KB, Netea SA, Condino-Neto A, Lau YL, Núñez Cuadros E, Toubiana J, Holanda Pena M, Rieux-Laucat F, Luyt CE, Haerynck F, Mège JL, Chakravorty S, Haddad E, Morin MP, Metin Akcan Ö, Keles S, Emiroglu M, Alkan G, Tüter Öz SK, Elmas Bozdemir S, Morelle G, Volokha A, Kendir-Demirkol Y, Sözeri B, Coskuner T, Yahsi A, Gulhan B, Kanik-Yuksek S, Bayhan GI, Ozkaya-Parlakay A, Yesilbas O, Hatipoglu N, Ozcelik T, Belot A, Chopin E, Barlogis V, Sevketoglu E, Menentoglu E, Gayretli Aydin ZG, Bloomfield M, AlKhater SA, Cyrus C, Stepanovskiy Y, Bondarenko A, Öz FN, Polat M, Fremuth J, Lebl J, Geraldo A, Jouanguy E, COVID-19 Human Genetic Effort, DIAMONDS, EUCLIDS, Carter MJ, Wellman P, Peters M, Pérez de Diego R, Edwards LA, Chiu C, Noursadeghi M, Bolze A, Shimizu C, Kaforou M, Hamilton MS, Herberg JA, Schmitt EG, Rodriguez-Palmero A, Pujol A, Kim J, Cobat A, Abel L, Zhang SY, Casanova JL, Kuijpers TW, Burns JC, Levin M, Hayday AC, Sancho-Shimizu V

A Thrombolytic Protocol of Bivalirudin for Giant Coronary Artery Aneurysms and Thrombosis in Kawasaki Disease.
Wang H, Dummer K, Tremoulet AH, Newburger J, Burns JC, VanderPluym C

FCGR2/3 polymorphisms are associated with susceptibility to Kawasaki disease but do not predict intravenous immunoglobulin resistance and coronary artery aneurysms.
Uittenbogaard P, Netea SA, Tanck MWT, Geissler J, Buda P, Kowalczyk-Domagała M, Okarska-Napierała M, van Stijn D, Tacke CE, US Kawasaki Disease Genetics Consortium, Burgner DP, Shimizu C, Burns JC, Kuipers IM, Kuijpers TW, Nagelkerke SQ

Plasma cell-free RNA signatures of inflammatory syndromes in children.
Loy CJ, Servellita V, Sotomayor-Gonzalez A, Bliss A, Lenz JS, Belcher E, Suslovic W, Nguyen J, Williams ME, Oseguera M, Gardiner MA, P.E.M.K.D.R.G., C.H.A.R.M.S. the Study Group, Choi JH, Hsiao HM, Wang H, Kim J, Shimizu C, Tremoulet AH, Delaney M, DeBiasi RL, Rostad CA, Burns JC, Chiu CY, De Vlaminck I

Plasma Cell-free RNA Signatures of Inflammatory Syndromes in Children.
Loy CJ, Servellita V, Sotomayor-Gonzalez A, Bliss A, Lenz J, Belcher E, Suslovic W, Nguyen J, Williams ME, Oseguera M, Gardiner MA, Pediatric Emergency Medicine Kawasaki Disease Research Group (PEMKDRG), CHARMS Study Group, Choi JH, Hsiao HM, Wang H, Kim J, Shimizu C, Tremoulet A, Delaney M, DeBiasi RL, Rostad CA, Burns JC, Chiu CY, Vlaminck I

The etiologies of Kawasaki disease.
Burns JC

More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C.
Franco A, Tremoulet A, Burns JC

Age-Dependent Variations in Kawasaki Disease Incidence in Japan.
DeHaan LL, Copeland CD, Burney JA, Nakamura Y, Yashiro M, Shimizu C, Miyata K, Burns JC, Cayan DR

SARS-CoV-2 variants are associated with different clinical courses in children with MIS-C.
Moreno Rojas AF, Bainto E, Harvey H, Tremoulet AH, Burns JC, Dummer KB

Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical data.
Lam JY, Song MS, Kim GB, Shimizu C, Bainto E, Tremoulet AH, Nemati S, Burns JC

Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease.
Payne RM, Burns KM, Glatz AC, Male C, Donti A, Brandão LR, Balling G, VanderPluym CJ, Bu'Lock F, Kochilas LK, Stiller B, Cnota JF 2nd, Rahkonen O, Khan A, Adorisio R, Stoica S, May L, Burns JC, Saraiva JFK, McHugh KE, Kim JS, Rubio A, Chía-Vazquez NG, Meador MR, Dyme JL, Reedy AM, Ajavon-Hartmann T, Jarugula P, Carlson-Taneja LE, Mills D, Wheaton O, Monagle P

Relevance of Obesity in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children Associated With COVID-19.
Dummer K, Burns JC

Coronary Sinus Thrombosis and Post-Myocardial Infarction Syndrome in Kawasaki Disease: Rare Causes of Pericardial Effusion.
Wang H, Pancheri JM, Appleton RS, Tremoulet AH, Burns JC, Dummer KB

DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease.
Dummer KB, Miyata K, Shimizu C, Tremoulet AH, Gleason J, Gordon JB, Burns JC

Subgroups of children with Kawasaki disease: a data-driven cluster analysis.
Wang H, Shimizu C, Bainto E, Hamilton S, Jackson HR, Estrada-Rivadeneyra D, Kaforou M, Levin M, Pancheri JM, Dummer KB, Tremoulet AH, Burns JC

See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.

PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.

Rady Children's updates the Doctor Finder annually. We are not responsible for omissions or errors. Prior to making an appointment, please be sure to check with your health plan to confirm coverage. If you see an error or omission on a physician's profile page, please contact us at refsvc@rchsd.org.